Vice President JD Vance recently attributed his weight loss to a high-protein diet featuring sauerkraut ,recommended by HHS Secretary Robert F. Kennedy Jr. This disclosure coincided with President Donald Trump's public comments regarding the high cost of GLP-1 medications and RFK Jr.'s critique of the president's own eating habits.
Sauerkraut and Protein: The RFK Jr. Blueprint for JD Vance
During a White House press briefing on September 3, Vice President JD Vance, 42, detailed how HHS Secretary Robert F. Kennedy Jr. guided his dietray shift. According to the report, Vance had initially considered cutting out sugar during Lent—a period of Christian prayer and self-denial—but Kennedy, 72, rejected that approach in favor of a more rigorous high-protein and sauerkraut-heavy regimen.
Vance was candid about the lack of pleasure associated with the diet, joking to the press corps, "My advice to you is if you want to lose weight, call Bobby Kennedy. And if you want to enjoy what you eat, do not call Bobby Kennedy." The Vice President also noted that his health journey began with a resolution made with his wife on Mardi Gras to abandon both social media and sugar, though Kennedy's specific nutritional advice eventually took precedence.
The $1,300 Ozempic Gap and the Wall Street Anecdote
While Vice President JD Vance focused on dietary discipline, President Donald Trump took a more abrasive approach to weight loss during a Rose Garden dinner. As the report says, Trump shared a story about an unnamed, "extremely obese" Wall Street friend who struggled with the cost of GLP-1 medications. Trump highlighted a stark price discrepancy, noting that his friend paid $1,300 for Ozempic in New York, whereas the same medication cost only $86 in London.
The President's commentary was not limited to economics; he admitted to telling his friend, "Its not working. You look like s***t." This blunt rhetoric underscores a recurring theme in the administration's communication style, where personal anecdotes and colorful language are used to frame complex public health and pharmaceutical issues.
TrumpRx and the November 2025 Deal with Eli Lilly and Novo Nordisk
The discussion regarding the high cost of "fat drugs" is not merely anecdotal, as it ties into a broader policy effort to lower medication prices. In November 2025, President Donald Trump announced the TrumpRx program, a deal involving pharmaceutical giants Eli Lilly and Novo Nordisk. The initiative is designed to reduce the financial burden on American consumers seeking weight-loss treatments.
However, the effectiveness of the TrumpRx program remains a point of contention. Drug-pricing experts have provided mixed assessments of the agreement, questioning how much actual savings will reach the end consumer. This tension reflects a wider struggle in the U.S. healthcare system to balance pharmaceutical profit margins with affordable access to life-altering medications.
The 'Unhinged' Eating Habits of President Donald Trump
Despite the administration's public focus on health and fitness, internal contradictions are surfacing. During a January 13 appearance on The Katie Miller Podcast, HHS Secretary Robert F. Kennedy Jr. was asked which cabinet member possessed the most "unhinged" eating habits.. Kennedy immediately identified President Donald Trump as the culprit.
This admission leaves several critical questions unanswered. Specifically, the report does not detail what constitutes "unhinged" eating in the eyes of the HHS Secretary, nor does it explain how Kennedy intends to reconcile the President's personal habits with the health mandates of the Department of Health and Human Services. It remains unclear if Kennedy's critique is a sign of internal friction or merely a candid observation of the President's well-known dietary preferences.
Comments 0